Form 8-K - Current report:
SEC Accession No. 0001140361-21-020180
Filing Date
2021-06-08
Accepted
2021-06-08 16:32:34
Documents
3
Period of Report
2021-06-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10025576_8k.htm 8-K 34385
2 EXHIBIT 99.1 brhc10025576_ex99-1.htm EX-99.1 12611
3 image0.jpg GRAPHIC 6484
  Complete submission text file 0001140361-21-020180.txt   57446
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 211002517
SIC: 2834 Pharmaceutical Preparations